OpenBCI
Brooklyn, US · Delaware corporation · 1 known investors
Founders & leadership
CR
Conor RussomannoExecutive Officer, Director, Promoter30 Under 30 2018
Investors · 1
Competitors · 10
by search overlapDiabetes Prevention Program305 shared keywords
ResearchGate219 shared keywords
Dervan et al203 shared keywords
EMOTIV165 shared keywordsEmotiv develops wearable EEG systems and software platforms that capture and analyze brain signals to support neuroscience research, brain-computer interfaces, and cognitive AI applications. The platform serves researchers, developers, and organizations seeking to understand brain function and enable human-computer interaction.
Biopac Systems, Inc.101 shared keywords
Built In87 shared keywords
Conor Walsh85 shared keywordsHarvard University is a higher-education and research institution whose schools and faculty conduct medical and scientific research across areas such as chronic disease, public health, and engineering. The page highlights research on conditions including cardiovascular disease, chronic pain, lung disease, and tissue engineering.
Bob Langer81 shared keywords
Columbia77 shared keywords
Cleveland Clinic, 202275 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Companies competing with OpenBCI for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$200KraisedSep 2024 · 4 investors · Other TechnologyRule 506(b)
▶$200KraisedSep 2024 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Conor RussomannoExecutive Officer, Director, Promoter
- Offering amount
- $1.9M
- Amount sold
- $200K
- Minimum investment
- $10K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$110KraisedMar 2023 · 2 investors · Other TechnologyRule 506(b)
▶$110KraisedMar 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Conor RussomannoExecutive Officer, Director, Promoter
- Offering amount
- $4M
- Amount sold
- $110K
- Minimum investment
- $10K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJan 2022 · 6 investors · Other TechnologyRule 506(b)
▶$1.3MraisedJan 2022 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Conor RussomannoExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- Minimum investment
- $10K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedOct 2021 · 5 investors · Other TechnologyRule 506(b)
▶$1.8MraisedOct 2021 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Conor RussomannoExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.8M
- Minimum investment
- $10K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2023 | $1.8M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
- Funding Proposal: "Brain Pong" with Clojure and OpenBCIdocs.google.com · 2025
- Funding Proposal: "Brain Pong" with Clojure and OpenBCIdocs.google.com · 2025